Literature DB >> 10812083

Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells.

R Villa1, M Folini, S Lualdi, S Veronese, M G Daidone, N Zaffaroni.   

Abstract

We investigated the effect of two peptide nucleic acids (PNAs), which are complementary to the RNA component of human telomerase, on the catalytic activity of the enzyme. PNAs induced a dose-dependent reduction of telomerase activity in cell extracts from human melanoma cell lines and surgical specimens. To down-regulate telomerase in intact cells, we generated a chimeric molecule synthesized by coupling the 13-mer PNA to the Antennapedia peptide. The PNA construct induced a dose- and time-dependent inhibition of telomerase activity. However, a 20-day exposure to the PNA construct only caused a slight increase in melanoma cell doubling time and failed to induce any telomere shortening.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10812083     DOI: 10.1016/s0014-5793(00)01540-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  PNA Technology.

Authors:  Peter E Nielsen
Journal:  Mol Biotechnol       Date:  2004-03       Impact factor: 2.695

2.  Targeting human telomerase for cancer therapeutics.

Authors:  Lionel Guittat; Patrizia Alberti; Dennis Gomez; Anne De Cian; Gaëlle Pennarun; Thibault Lemarteleur; Chafke Belmokhtar; Rajaa Paterski; Hamid Morjani; Chantal Trentesaux; Eliane Mandine; François Boussin; Patrick Mailliet; Laurent Lacroix; Jean-François Riou; Jean-Louis Mergny
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

3.  Introduction and History of the Chemistry of Nucleic Acids Therapeutics.

Authors:  Michael J Gait; Sudhir Agrawal
Journal:  Methods Mol Biol       Date:  2022

4.  Using peptide nucleic acids as gene-expression modifiers to reduce beta-amyloid levels.

Authors:  Beth M McMahon; Jennifer Stewart; Abdul Fauq; Steven Younkin; Linda Younkin; Elliott Richelson
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

5.  Radiolabeled Oligonucleotides Targeting the RNA Subunit of Telomerase Inhibit Telomerase and Induce DNA Damage in Telomerase-Positive Cancer Cells.

Authors:  Mark R Jackson; Bas M Bavelaar; Philip A Waghorn; Martin R Gill; Afaf H El-Sagheer; Tom Brown; Madalena Tarsounas; Katherine A Vallis
Journal:  Cancer Res       Date:  2019-07-16       Impact factor: 13.312

6.  Telomerase activity in human leukemic cells with or without monosomy 7 or 7q-.

Authors:  Nedime Serakinci; Jørn E Koch
Journal:  BMC Med Genet       Date:  2002-10-29       Impact factor: 2.103

Review 7.  Cell penetrating peptide conjugates of steric block oligonucleotides.

Authors:  Bernard Lebleu; Hong M Moulton; Rachida Abes; Gabriela D Ivanova; Said Abes; David A Stein; Patrick L Iversen; Andrey A Arzumanov; Michael J Gait
Journal:  Adv Drug Deliv Rev       Date:  2007-10-22       Impact factor: 15.470

Review 8.  PML body meets telomere: the beginning of an ALTernate ending?

Authors:  Inn Chung; Sarah Osterwald; Katharina I Deeg; Karsten Rippe
Journal:  Nucleus       Date:  2012-05-01       Impact factor: 4.197

9.  Peptide nucleic acids targeted to the amyloid precursor protein.

Authors:  Beth M McMahon; Jennifer Stewart; Abdul Fauq; Steven Younkin; Linda Younkin; Elliott Richelson
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.